Pfizer GLP-1 Drug Passes Preliminary Review For China’s Medical Insurance Drug List
Pfizer's GLP-1 drug passes preliminary review for China's medical insurance drug list.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Pfizer's GLP-1 drug passes preliminary review for China's medical insurance drug list.